Insulet Reports Strong Clinical Results for Next-Generation Omnipod 6 and Closed-Loop System at ADA Conference

Insulet Corporation (NASDAQ: PODD) announced on June 6, 2026 that two clinical studies—STRIVE and EVOLUTION 3—have p...

Read story →